Pfizer and Schlumberger are January Bounce Candidates

Published on 25 Nov 2024 on GuruFocus.com · via Yahoo Finance

Here are five Comeback Candidates for 2024. Pfizer The world's largest pharmaceutical company by...

Read the rest of the article

Start tracking your investments with Statfolio

But over the last 5 years, Disney shares are still down 22.5%. Disney isn’t cheap. It has a forwa...

Zacks · via Yahoo Finance 28 Nov 2024

We recently published a list of 8 Most Undervalued Pot Stocks to Buy According to Analysts. In th...

Insider Monkey · via Yahoo Finance 28 Nov 2024

It is not uncommon to see a big share price drop if two large institutional investors try to sell...

Simply Wall St. · via Yahoo Finance 27 Nov 2024

Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...

Zacks · via Yahoo Finance 26 Nov 2024

On Friday, the FDA approved BridgeBio Pharma, Inc.’s (NASDAQ:BBIO) Attruby (acoramidis), an...

Benzinga · via Yahoo Finance 25 Nov 2024

Each year, I offer a few January bounce candidates ones that I also think may sustain gains durin...

Investing.com 25 Nov 2024

Here are five Comeback Candidates for 2024. Pfizer The world's largest pharmaceutical company by...

GuruFocus.com · via Yahoo Finance 25 Nov 2024

Donald Trump’s victory is positive for the stock market. The healthcare sector has underperformed...

247wallst.com 25 Nov 2024

For Immediate Release Chicago, IL – November 21, 2024 – Zacks.com announces the list of Stocks...

Zacks · via Yahoo Finance 21 Nov 2024

Year to date, the three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — hav...

Zacks · via Yahoo Finance 20 Nov 2024